Compare CTBI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTBI | CRMD |
|---|---|---|
| Founded | 1903 | 2006 |
| Country | United States | United States |
| Employees | 930 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 561.8M |
| IPO Year | 1995 | 2009 |
| Metric | CTBI | CRMD |
|---|---|---|
| Price | $58.64 | $6.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $59.00 | $14.67 |
| AVG Volume (30 Days) | 49.6K | ★ 1.5M |
| Earning Date | 01-01-0001 | 06-05-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | 17.79 | ★ 780.00 |
| EPS | ★ 5.43 | 2.04 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | $14.02 | $1.10 |
| Revenue Next Year | $4.30 | N/A |
| P/E Ratio | $10.95 | ★ $3.26 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $44.60 | $5.60 |
| 52 Week High | $65.79 | $17.43 |
| Indicator | CTBI | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.95 | 39.41 |
| Support Level | $53.38 | $6.55 |
| Resistance Level | $59.48 | $7.44 |
| Average True Range (ATR) | 1.84 | 0.29 |
| MACD | -0.47 | 0.01 |
| Stochastic Oscillator | 25.53 | 39.16 |
Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.